Loading
Animal Testing and Alternatives · Journal article
Birth Defects Research · September 1, 2026
Raises a question worth testing. It does not answer one.
This is an opinion and advocacy piece that identifies perceived problems in regulatory DART decision-making—specifically that some regulatory scientists lack sufficient training in embryology and toxicology, and that unqualified individuals have been appointed to leadership roles, resulting in false classification of substances as teratogens. The text proposes remedies but presents no empirical evidence, case studies, rates of misclassification, or comparative analysis to substantiate the alleged crisis.
Journal article.
Many regulatory scientists lack whole-animal DART testing experience and formal training in embryology, developmental biology, comparative anatomy, and epidemiology. Some medicines and chemicals have been misidentified as developmental toxicants due to inadequate expertise and interpretation. Unqualified individuals have been appointed to health leadership roles whose mandates are accepted without independent expert evaluation.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
If the concerns raised are valid, they could affect regulatory classification of drugs and chemicals as teratogens; however, without quantitative evidence of misclassification or clinical harm, clinicians cannot assess the scope or severity of the alleged problem or adjust practice accordingly.
A critical opinion piece raising concerns about regulatory decision-making in DART testing, without empirical evidence of misclassification rates, outcomes, or systematic analysis to support the claims of crisis.
If the concerns raised are valid, they could affect regulatory classification of drugs and chemicals as teratogens; however, without quantitative evidence of misclassification or clinical harm, clinicians cannot assess the scope or severity of the alleged problem or adjust practice accordingly.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Developmental and reproductive toxicity testing (DART) safety tests are expensive and time-consuming. The future of DART testing is trending toward in vitro and in silico systems (and potentially artificial intelligence). Forward-looking academic programs have embraced the new test systems, but regulatory decisions remain based on decades-old, whole-animal testing. Many regulatory scientists have neither whole-animal DART testing experience nor academic training in embryology/developmental biology, comparative anatomy, and epidemiology. Consequently, some new medicines and chemicals have been misidentified as developmental toxicants by those eager to protect the public but lacking requisite in-depth DART/epidemiology training/experience to make informed interpretations. Additionally, some unqualified individuals have been appointed to health leadership roles. Sadly, their mandates are often accepted forthwith, foregoing independent evaluation by experts, resulting in misclassification of substances as "teratogens by fiat"-Regulatogens. Potential long-term remedies to address this crisis are discussed, but implementation and effective results will take years. Immediate remedies require qualified scientists/experts to step forward and challenge the validity and interpretation of poor science/improper interpretation underlying decisions that lack rigor, and proffer appropriately interpreted data with conclusions that are explainable to all stakeholders, including the public.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.